Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia

No abstract is available for this paper.

• Publication year

  1995

• Venue

  British Journal of Haematology

• Publication date

  1995-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.1995.tb05581.xPMID 7646991
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenetic mechanisms of septic shock.

  1993cited by this paper
• Cathepsin G, a Polymorphonuclear Cell Protease, Affects the Fibrinolytic System by Releasing PAI‐1 from Endothelial Cells and Platelets a

  1992cited by this paper
• Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor.

  1990cited by this paper
• The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelet

  1990cited by this paper
• Plasminogen Activator Inhibitor 1: A New Prognostic Marker in Septic Shock

  1989cited by this paper
• An Enzyme-Linked Immunosorbent Assay (ELISA) Used to Study the Cellular Secretion of Endothelial Plasminogen Activator Inhibitor (PAI-1)

  1988cited by this paper
• Plasminogen Activator Inhibitor Activity in Bacterial Infection

  1988cited by this paper
• Plasminogen activator inhibitor (PAI‐1) in plasma and platelets

  1988cited by this paper
• Plasminogen activator-specific inhibitors produced by human monocytes/macrophages

  1987cited by this paper
• A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator

  1987cited by this paper
• A New Kit for the Determination of Tissue Plasminogen Activator and its Inhibitor in Blood

  1987cited by this paper
• Interaction of Polymorphonuclear Cells with Contact Activation Factors

  1987cited by this paper
• Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections

  1987cited by this paper
• Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

  1986cited by this paper
• Platelet release protein which inhibits plasminogen activators.

  1985cited by this paper
• Haemostatic response to trauma.

  1985cited by this paper
• Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

  1984cited by this paper
• Shock revisited.

  1984cited by this paper
• Neutrophils and Lung Edema: State of the Art

  1982cited by this paper
• Complement Activation And C1q Binding Activity In Haemodialysis

  1981cited by this paper
• Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.

  1981cited by this paper
• Comparative Studies on Human Activators of Plasminogen

  1981cited by this paper
• Procoagulant-tissue factor activity of circulating peripheral blood leukocytes. Results of in vivo studies.

  1980cited by this paper
• Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects.

  1977cited by this paper
• Lipid A as the biologically active moiety in bacterial endotoxin (LPS)-initiated generation of procoagulant activity by peripheral blood leukocytes.

  1977cited by this paper
• An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

  1975cited by this paper
• PEROXIDASE-LABELED ANTIBODY A NEW METHOD OF CONJUGATION

  1974cited by this paper
• Renal Cortical Fibrinolytic Activity in the Rabbit Following One or Two Doses of Endotoxin

  1973cited by this paper
• Coagulant activity of leukocytes. Tissue factor activity.

  1972cited by this paper
• THE PATHOPHYSIOLOGY OF GRAM‐NEGATIVE SEPTICAEMIA

  1972cited by this paper
• Disseminated intravascular coagulation induced with leukocyte procoagulant.

  1972cited by this paper
• Stimulation of Human Leukocyte Thromboplastic Activity by Endotoxin 1

  1971cited by this paper
• The mechanism of pulmonary damage following traumatic shock.

  1970cited by this paper
• Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response.

  1969cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper
• The fibrin plate method for estimating fibrinolytic activity.

  1952cited by this paper
• STUDIES ON THE GENERALIZED SHWARTZMAN REACTION

  1952cited by this paper
• STUDIES ON THE MECHANISM OF THE SHWARTZMAN PHENOMENON

  1950cited by this paper
• STUDIES ON THE MECHANISM OF THE SHWARTZMAN PHENOMENON

  1949cited by this paper
• Studies on the mechanism of the Schwartzman phenomenon.

  1948cited by this paper

• Sepsis grave y shock séptico en urgencias

  2017cites this paper
• Sepsis sévère et choc septique aux urgences

  2017cites this paper
• Shock settico

  2011cites this paper
• Cancer patients with septic shock: mortality predictors and neutropenia

  2004cites this paper
• Polymorphonuclear leukocytes from patients with severe sepsis have lost the ability to degrade fibrin via u‐PA

  2004cites this paper
• Neutropenia and the development of the systemic inflammatory response syndrome

  2002cites this paper
• Interference with the Coagulation System

  2002cites this paper
• Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion

  2002cites this paper
• Early Inhibition of Activated Fibrinolysis Predicts Microbial Infection, Shock and Mortality in Febrile Medical Patients

  2001cites this paper
• Plasminogen activator inhibitor 2 and urokinase‐type plasminogen activator in plasma and leucocytes in patients with severe sepsis

  2000cites this paper
• Protective effects of leukopenia and tissue plasminogen activator in microvascular ischemia-reperfusion injury.

  2000cites this paper
• Storungen der Blutgerinnung und Fibrinolyse

  2000cites this paper
• Monocyte and Haemostasis.

  1998cites this paper
• Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic Shock

  1998cites this paper
• Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.

  1997cites this paper
• Interactions of neutrophils and coagulation proteins.

  1997cites this paper
• Systemic inflammatory response syndrome

  1997cites this paper
• Tissue Factor in Health and Disease

  1997cites this paper
• Increase of Plasminogen Activator Inhibitor Levels Predicts Outcome of Leukocytopenic Patients with Sepsis

  1996cites this paper
• Inhibitors of Plasminogen Activator in Neutrophils and Mononuclear Cells from Septic Patients

  1995cites this paper